Home Cart 0 Sign in  

[ CAS No. 3605-01-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 3605-01-4
Chemical Structure| 3605-01-4
Structure of 3605-01-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3605-01-4 ]

Related Doc. of [ 3605-01-4 ]

Alternatived Products of [ 3605-01-4 ]

Product Details of [ 3605-01-4 ]

CAS No. :3605-01-4 MDL No. :MFCD00868264
Formula : C16H18N4O2 Boiling Point : -
Linear Structure Formula :- InChI Key :OQDPVLVUJFGPGQ-UHFFFAOYSA-N
M.W : 298.34 Pubchem ID :4850
Synonyms :
Trivastal;Trivastan;EU 4200;ET 495

Calculated chemistry of [ 3605-01-4 ]

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.38
Num. rotatable bonds : 3
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 88.84
TPSA : 50.72 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.88
Log Po/w (XLOGP3) : 1.78
Log Po/w (WLOGP) : 0.61
Log Po/w (MLOGP) : 1.18
Log Po/w (SILICOS-IT) : 1.68
Consensus Log Po/w : 1.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.02
Solubility : 0.287 mg/ml ; 0.000962 mol/l
Class : Soluble
Log S (Ali) : -2.46
Solubility : 1.03 mg/ml ; 0.00344 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.1
Solubility : 0.0238 mg/ml ; 0.0000796 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.54

Safety of [ 3605-01-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3605-01-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3605-01-4 ]
  • Downstream synthetic route of [ 3605-01-4 ]

[ 3605-01-4 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 495-76-1 ]
  • [ 20980-22-7 ]
  • [ 3605-01-4 ]
YieldReaction ConditionsOperation in experiment
85% With Raney nickel In 5,5-dimethyl-1,3-cyclohexadiene for 24 h; Reflux General procedure: The prepared grades of R-Ni were weighed in water after considering its specific gravity. The residual water was removed using dean stark apparatus. (0043) All the reactions were carried out in a 2-neck round bottom flask, attached with a condenser. Typically, reaction was carried out by stirring and refluxing the reaction mixture of amine and alcohol with pretreated R-Ni in 20ml solvent. After reaction completion, reaction mixture was cooled and filtered using Whatman filter paper 40. The solvent was removed in vacuo. The mixture thus obtained was purified using column chromatography. The purified compounds obtained were characterized by IR, NMR, LC–MS and melting or boiling point. The analytical data obtained of the known compounds are in agreement to the reported literature.
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 27, p. 9656 - 9661
[2] ChemCatChem, 2014, vol. 6, # 3, p. 808 - 814
[3] Chemistry - A European Journal, 2013, vol. 19, # 11, p. 3665 - 3675
[4] Journal of Organic Chemistry, 2011, vol. 76, # 7, p. 2328 - 2331
[5] Tetrahedron Letters, 2007, vol. 48, # 47, p. 8263 - 8265
[6] Journal of the American Chemical Society, 2009, vol. 131, p. 1766 - 1774
[7] Applied Catalysis A: General, 2014, vol. 478, p. 241 - 251
[8] Journal of Organic Chemistry, 2017, vol. 82, # 13, p. 6604 - 6614
[9] Angewandte Chemie - International Edition, 2017, vol. 56, # 46, p. 14702 - 14706[10] Angew. Chem., 2017, vol. 129, # 46, p. 14894 - 14898,5
[11] Green Chemistry, 2012, vol. 14, # 1, p. 226 - 232
  • 2
  • [ 20850-43-5 ]
  • [ 20980-22-7 ]
  • [ 3605-01-4 ]
YieldReaction ConditionsOperation in experiment
92% With triethylamine In isopropyl alcohol at 20 - 50℃; 50 g of 2-piperazin-1-ylpyrimidine, 60 g of triethylamine and 170 ml of isopropyl alcohol were put into a 100 ml three-necked reaction flask, and 58 g of piperonyl chloride was added dropwise with stirring at room temperature, and the mixture was dropped in 30 minutes, heated to 50 °C, stirring to cool to room temperature, filtration, recovery of mother liquor, filter cake by adding 100ml water beating, pumping, plus 50ml water washing cake. Dried at 50 °C, 71.5 g of piribedil crude and 99.1percent by HPLC. Yield 92percent.
52% With potassium carbonate In 5,5-dimethyl-1,3-cyclohexadiene at 130℃; for 9 h; 16.4 g of piperazinylpyrimidine was dissolved in 300 ml of xylene, 28 g of potassium carbonate and 18 g of piperonyl chloride were added and the suspension was incubated at reflux temperature (130C) for 9 hours, cooled, extracted with 10percent hydrochloric acid several times,The separated hydrochloric acid solution is washed with ether, the acid solution is transferred to alkaline by potassium carbonate, the organic phase is separated, the aqueous phase is extracted with chloroform, the combined organic phase is dried with potassium carbonate, filtered and the solvent is removed by distillation,20 g of the residual oily organics was obtained and recrystallized from ethanol to give 15 g of product, piribedil, yield 52percent.
14.76 g With triethylamine In isopropyl alcohol at 20 - 50℃; for 2.5 h; ake 10g about 89.7percent content of piperazine pyrimidine, 12g triethylamine, 34ml isopropanol into 100ml three reaction flask, dropping peppermint chloride at room temperature under stirring, dropping over 30 minutes. Heated to 50 , incubated for 2 hours, cooled to room temperature with stirring, filtered, the mother liquor was recovered, the filter cake was added 20ml water beating, suction filtration, plus 10ml water washing cake. 50 drying, get piribedil crude 16.6g, HPLC analysis content of 99.2percent. Yield 92percent; 16g of crude piribedil (99.2percent), 0.3g of activated charcoal and 42ml of absolute ethanol were added into a 100ml single-necked flask and heated to the reflux temperature for 0.5 hour. The activated carbon was removed by hot filtration and the filtrate was cooled and crystallized under stirring to obtain a white Crystalline solid. Filtered, rinsed with a small amount of anhydrous ethanol, and dried to obtain 14.76g of the first crystal product of piribedil, the content of which was 99.90percent by HPLC and the refined yield was 90.33percent.
Reference: [1] Patent: CN106432212, 2017, A, . Location in patent: Paragraph 0010; 0019
[2] Patent: CN106432212, 2017, A, . Location in patent: Paragraph 0016
[3] Patent: CN107216318, 2017, A, . Location in patent: Paragraph 0022; 0025; 0028
[4] Patent: CN107266429, 2017, A, . Location in patent: Paragraph 0022; 0025; 0028
  • 3
  • [ 94-53-1 ]
  • [ 20980-22-7 ]
  • [ 3605-01-4 ]
YieldReaction ConditionsOperation in experiment
85% With tris(pentafluorophenyl)borate; phenylsilane In dibutyl ether at 140℃; for 24 h; Schlenk technique; Inert atmosphere; Green chemistry In the same procedure as in Example 1, The reaction mixture was then heated at 140 ° C for 24 h and cooled to room temperature. The resulting white crystals were isolated by the same post-treatment to yield 85percent yield.The obtained product was subjected to nuclear magnetic resonance spectroscopy and nuclear magnetic resonance spectroscopy to confirm that the obtained product was 2- [4- (1,3-benzodioxol-5-ylmethyl) _ Base] pyrimidine, that ie piribedil. [0050] In a 10 mL Schlenk reaction tube (Beijing Xinwei Er Glass Instrument Co., Ltd., F891410 reaction tube, Capacity 10mL, Grinding mouth 14/20) was added 0.005 mmol of tris (pentafluorophenyl) boron, The inside of the tube is replaced with argon, Then, 1.5 mL of n-butyl ether and 2.0 mmol of phenyl silane were added under argon atmosphere and stirred (using an IKA magnetic stirrer, RCT basic, Stirring speed of 500 rpm). Followed by the addition of 0.5 mmol of 1- (2-pyrimidinyl) piperazine and 1.0 mmol ofd piperic acid. After heating at 100 ° C for 20 h, the mixture was cooled to room temperature. Quenched with sodium hydroxide solution (3M; 3 mL) Ethyl acetate (3 mL) was added, After stirring at room temperature for 3 h, Ethyl acetate extraction (2 mL x 3), The organic phase was dried over anhydrous sodium sulfate, Filtration, organic phase through the rotary evaporator (Swiss step Qi Co., Ltd., BUCHI Rotary Evaporator R-3) Concentrated, And then through the column (Beijing Xin Wei Er Glass Instrument Co., Ltd., C383040C with sand plate storage column chromatography column, 35/20, φ30mm, effective length: 500ml) Chromatography to obtain white crystal products, Yield 41percent. The resulting product was subjected to 1H-NMR (400 MHz, CDCl3) and nuclear magnetic resonance spectroscopy 13C-NMR (101 MHz, CDCl3) analysis, The resulting spectra are shown in Figure 1-2. The resulting product was confirmed to be 2- [4- (1,3-benzodioxol-5-ylmethyl) piperazin-1-yl] pyrimidine, i.e piribedil
Reference: [1] Patent: CN104926799, 2017, B, . Location in patent: Paragraph 0050; 0051; 0055; 0058; 0060-0062; 0064; 0067
[2] Angewandte Chemie - International Edition, 2015, vol. 54, # 31, p. 9042 - 9046[3] Angew. Chem., 2015, vol. 127, # 31, p. 9170 - 9174,5
  • 4
  • [ 1722-12-9 ]
  • [ 3605-01-4 ]
YieldReaction ConditionsOperation in experiment
80% With triethylamine In ethanol at 95 - 100℃; for 1 h; The intermediate intermediate piperonyl piperazine, 360 ml of absolute ethanol and 120 ml of triethylamine were placed in a 1000 ml three-necked reaction flask and heated to 95 ° C to 100 ° C with stirring. A mixed solution of 70 g of dichloropyrimidine and 360 ml of absolute ethanol was added dropwise, and the mixture was incubated at 95 ° C to 100 ° C for 1 hour, distilled under reduced pressure, and about 400 ml of ethanol and triethylamine solution were removed, cool to room temperature and filter. Atmospheric distillation, remove the ethanol and triethylamine about 250ml, cooled to room temperature, filter the solid, add water, beating, pumping filter, to get piribedil crude 160g, content 92percent, the total yield of 80percent.
Reference: [1] Patent: CN106432212, 2017, A, . Location in patent: Paragraph 0010; 0020
  • 5
  • [ 20980-22-7 ]
  • [ 93-54-9 ]
  • [ 3605-01-4 ]
YieldReaction ConditionsOperation in experiment
76% With trifuran-2-yl-phosphane; palladacycle; lithium hydroxide In neat (no solvent) at 120℃; for 24 h; Inert atmosphere; Molecular sieve General procedure: An oven dried Schlenk tube was charged with LiOH (1.5 mmol), pre-catalyst (1.5*10-2 mmol), P(2-Fur)3 (3*10-2 mmol) and activated 4 Å MS (100 mg). The tube was connected to a vacuum line under argon and purged three times. To the reaction mixture, sulfanilamide (3.0 mmol) and arylalcohol (6.0 mmol) were added. The Schlenk tube was closed with PTFE stopper and the reaction mixture was stirred at 120 °C for 24 h. At the end of the reaction time, the reaction mixture was cooled to room temperature, diluted with methanol (5 mL), and the tube was washed with methanol three more times (3*2 mL). The methanol solution was concentrated under vacuum and the crude was subjected to flash column chromatography on silica gel using ethyl acetate and n-hexane mixtures to afford the N-alkylated product.
Reference: [1] Tetrahedron, 2017, vol. 73, # 16, p. 2225 - 2233
  • 6
  • [ 1722-12-9 ]
  • [ 32231-06-4 ]
  • [ 3605-01-4 ]
YieldReaction ConditionsOperation in experiment
44% With potassium carbonate In tetrahydrofuran for 2 h; Reflux 250 ml of a three-necked flask was added 50 g of piperonyl piperazine, 26 g of dichloropyrimidine, 330 ml of tetrahydrofuran and 65 g of potassium carbonate, and the mixture was heated under reflux for 2 hours. The mixture was cooled and cooled, and 1600 ml of distilled water was added thereto, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated to dryness to obtain a dark red viscous liquid (56.3 g). Add 40ml of anhydrous ethanol, dissolve, slightly cold, add activated carbon 40g, reflux 30 minutes, hot filter, cooling, precipitation of white solid, filtration, 40 °C vacuum drying to get 30.2 g of white crystalline powder, yield 44percent.
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 16, p. 9144 - 9155
[2] Patent: CN106432212, 2017, A, . Location in patent: Paragraph 0015
  • 7
  • [ 120-57-0 ]
  • [ 20980-22-7 ]
  • [ 3605-01-4 ]
Reference: [1] ChemCatChem, 2018, vol. 10, # 6, p. 1235 - 1240
[2] Chemistry - A European Journal, 2017, vol. 23, # 9, p. 2217 - 2224
[3] Tetrahedron Letters, 2006, vol. 47, # 15, p. 2549 - 2552
[4] Patent: US2005/215788, 2005, A1, . Location in patent: Page/Page column 1; 2
  • 8
  • [ 20980-22-7 ]
  • [ 3605-01-4 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 3, p. 544 - 547
  • 9
  • [ 2635-13-4 ]
  • [ 145208-86-2 ]
  • [ 3605-01-4 ]
YieldReaction ConditionsOperation in experiment
127.6 g for 4 h; Reflux; Green chemistry To a solution of ethyl 2-(4-methylpiperazin-1-yl)pyrimidine ethyl ester prepared in Step a was added 4-bromo-1,2-methylenedioxybenzene, the compound IV130.6g was added and the temperature was raised to reflux Reaction 4h, After the reaction, the reaction solution has a degree of vacuum of not less than 0.09 MPa, At a temperature of 40~50 ° C under reduced pressure to remove ethyl acetate, The residue was added with 200 mL of purified water and stirred for 20 min, filter, piribedil crude weight 192.1g; c, purification of piribedil: The crude piribedil was added to the reactor, then 1.15 L of anhydrous ethanol was added, heated to dissolve, and activated charcoal 9.6g, continue to heat for 30min, the reaction after the hot filter, the filtrate naturally cooled to room temperature, room temperature crystallization 2h, filter, filter cake placed at 40~45 °C temperature drying 8h, get piribedil finished product 127.6g.
Reference: [1] Patent: CN106749204, 2017, A, . Location in patent: Paragraph 0012; 0013; 0014; 0015
  • 10
  • [ 120-57-0 ]
  • [ 20980-22-7 ]
  • [ 88268-16-0 ]
  • [ 3605-01-4 ]
Reference: [1] Archiv der Pharmazie, 1993, vol. 326, # 4, p. 241 - 242
  • 11
  • [ 64-18-6 ]
  • [ 20980-22-7 ]
  • [ 88268-16-0 ]
  • [ 3605-01-4 ]
Reference: [1] Archiv der Pharmazie, 1993, vol. 326, # 4, p. 241 - 242
  • 12
  • [ 780705-64-8 ]
  • [ 3605-01-4 ]
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 15, p. 2549 - 2552
  • 13
  • [ 120-57-0 ]
  • [ 3605-01-4 ]
Reference: [1] Patent: CN106432212, 2017, A,
Same Skeleton Products
Historical Records